Kim YC - Search Results

1

Induction of apoptosis by a novel indirubin-5-nitro-3'-monoxime, a CDK inhibitor, in human lung cancer cells.

Lee JW, Moon MJ, Min HY, Chung HJ, Park EJ, Park HJ, Hong JY, Kim YC, Lee SK. Lee JW, et al. Among authors: kim yc. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3948-52. doi: 10.1016/j.bmcl.2005.05.105. Bioorg Med Chem Lett. 2005. PMID: 15993584

2

N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.

Jeong LS, Jin DZ, Kim HO, Shin DH, Moon HR, Gunaga P, Chun MW, Kim YC, Melman N, Gao ZG, Jacobson KA. Jeong LS, et al. Among authors: kim ho, kim yc. J Med Chem. 2003 Aug 28;46(18):3775-7. doi: 10.1021/jm034098e. J Med Chem. 2003. PMID: 12930138

3

Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors.

Oh M, Im I, Lee YJ, Kim YH, Yoon JH, Park HG, Higashiyama S, Kim YC, Park WJ. Oh M, et al. Among authors: kim yh, kim yc. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6071-4. doi: 10.1016/j.bmcl.2004.09.082. Bioorg Med Chem Lett. 2004. PMID: 15546732

4

Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities.

Moon MJ, Lee SK, Lee JW, Song WK, Kim SW, Kim JI, Cho C, Choi SJ, Kim YC. Moon MJ, et al. Among authors: kim ji, kim sw, kim yc. Bioorg Med Chem. 2006 Jan 1;14(1):237-46. doi: 10.1016/j.bmc.2005.08.008. Epub 2005 Sep 22. Bioorg Med Chem. 2006. PMID: 16182537

5

Enhancing effect of indirubin derivatives on 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced differentiation of HL-60 leukemia cells.

Kim SH, Kim SW, Choi SJ, Kim YC, Kim TS. Kim SH, et al. Among authors: kim ts, kim sw, kim yc. Bioorg Med Chem. 2006 Oct 1;14(19):6752-8. doi: 10.1016/j.bmc.2006.05.044. Epub 2006 Jun 12. Bioorg Med Chem. 2006. PMID: 16765600

6

Antitumor activity of novel indirubin derivatives in rat tumor model.

Kim SA, Kim YC, Kim SW, Lee SH, Min JJ, Ahn SG, Yoon JH. Kim SA, et al. Among authors: kim sw, kim yc. Clin Cancer Res. 2007 Jan 1;13(1):253-9. doi: 10.1158/1078-0432.CCR-06-1154. Clin Cancer Res. 2007. PMID: 17200363

7

Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.

Jung KY, Moon HD, Lee GE, Lim HH, Park CS, Kim YC. Jung KY, et al. Among authors: kim yc. J Med Chem. 2007 Sep 6;50(18):4543-7. doi: 10.1021/jm070114m. Epub 2007 Aug 3. J Med Chem. 2007. PMID: 17676725

8

Synthesis and structure-activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor.

Lee GE, Joshi BV, Chen W, Jeong LS, Moon HR, Jacobson KA, Kim YC. Lee GE, et al. Among authors: kim yc. Bioorg Med Chem Lett. 2008 Jan 15;18(2):571-5. doi: 10.1016/j.bmcl.2007.11.077. Epub 2007 Nov 28. Bioorg Med Chem Lett. 2008. PMID: 18078749 Free PMC article.

9

Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling.

Lee MJ, Kim MY, Mo JS, Ann EJ, Seo MS, Hong JA, Kim YC, Park HS. Lee MJ, et al. Among authors: kim yc, kim my. Cancer Lett. 2008 Jul 8;265(2):215-25. doi: 10.1016/j.canlet.2008.02.013. Epub 2008 Mar 17. Cancer Lett. 2008. PMID: 18343569

10

Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists.

Lee GE, Lee HS, Lee SD, Kim JH, Kim WK, Kim YC. Lee GE, et al. Among authors: kim wk, kim yc, kim jh. Bioorg Med Chem Lett. 2009 Feb 1;19(3):954-8. doi: 10.1016/j.bmcl.2008.11.088. Epub 2008 Nov 27. Bioorg Med Chem Lett. 2009. PMID: 19110420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,292 results

Search Page

Filters